Alignment Healthcare Inc [ALHC] stock prices are up 0.21% to $4.71 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The ALHC shares have lost -1.88% over the last week, with a monthly amount drifted -2.28%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Alignment Healthcare Inc [NASDAQ: ALHC] stock has seen the most recent analyst activity on March 06, 2024, when Barclays initiated its Underweight rating and assigned the stock a price target of $4.50. Previously, Piper Sandler downgraded its rating to Neutral on March 06, 2024, and dropped its price target to $6. On January 24, 2024, Stifel initiated with a Buy rating and assigned a price target of $11 on the stock. BofA Securities downgraded its rating to a Neutral and decreased its price target to $7.25 on November 02, 2023. Raymond James upgraded its rating to a Strong Buy and raised its price target to $10 on October 16, 2023. Stephens started tracking with a Equal-Weight rating for this stock on October 12, 2023, and assigned it a price target of $9. In a note dated May 01, 2023, Raymond James upgraded an Outperform rating on this stock but restated the target price of $9.
The stock price of Alignment Healthcare Inc [ALHC] has been fluctuating between $4.46 and $9.20 over the past year. Currently, Wall Street analysts expect the stock to reach $9.5 within the next 12 months. Alignment Healthcare Inc [NASDAQ: ALHC] shares were valued at $4.71 at the most recent close of the market. An investor can expect a potential return of 101.7% based on the average ALHC price forecast.
Analyzing the ALHC fundamentals
The Alignment Healthcare Inc [NASDAQ:ALHC] reported sales of 1.82B for trailing twelve months, representing a surge of 28.63%. Gross Profit Margin for this corporation currently stands at 0.11% with Operating Profit Margin at -0.07%, Pretax Profit Margin comes in at -0.08%, and Net Profit Margin reading is -0.08%. To continue investigating profitability, this company’s Return on Assets is posted at -0.25, Equity is -0.76 and Total Capital is -0.39. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.64 points at the first support level, and at 4.57 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.79, and for the 2nd resistance point, it is at 4.88.
Ratios To Look Out For
It’s worth pointing out that Alignment Healthcare Inc [NASDAQ:ALHC]’s Current Ratio is 1.84. Considering the valuation of this stock, the price to sales ratio is 0.49, the price to book ratio is 5.67.
Transactions by insiders
Recent insider trading involved Maroney Dawn Christine, President, Markets, that happened on Mar 28 ’24 when 10151.0 shares were sold. Chief Experience Officer, Kardes Hakan completed a deal on Mar 28 ’24 to sell 4363.0 shares. Meanwhile, Chief Financial Officer Freeman Robert Thomas sold 4299.0 shares on Mar 28 ’24.
